{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:59:00Z","timestamp":1775152740967,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jcv.2010.01.018","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T10:45:09Z","timestamp":1267181109000},"page":"330-334","source":"Crossref","is-referenced-by-count":15,"title":["Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting"],"prefix":"10.1016","volume":"47","author":[{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasak","family":"Wiboonchutikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasun","family":"Chantratita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnuek","family":"Sungkanuparph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2010.01.018_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/01.aids.0000237365.18747.13","article-title":"National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?","volume":"20","author":"Beck","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2010.01.018_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1545109706294288","article-title":"High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A\/E is predominant","volume":"5","author":"Chetchotisakd","year":"2006","journal-title":"J Int Assoc Physicians AIDS Care (Chicago, IL)"},{"key":"10.1016\/j.jcv.2010.01.018_bib3","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1097\/QAD.0b013e328235a527","article-title":"HIV drug resistance after the use of generic fixed-dose combination stavudine\/lamivudine\/nevirapine as standard first-line regimen","volume":"21","author":"Marcelin","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2010.01.018_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/510745","article-title":"Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails","volume":"44","author":"Sungkanuparph","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2010.01.018_bib5","series-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2008"},{"key":"10.1016\/j.jcv.2010.01.018_bib6","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1128\/AAC.48.12.4680-4686.2004","article-title":"TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1","volume":"48","author":"Andries","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcv.2010.01.018_bib7","first-page":"62","article-title":"Update of the drug resistance mutations in HIV-1: spring 2008","volume":"16","author":"Johnson","year":"2008","journal-title":"Top HIV Med"},{"key":"10.1016\/j.jcv.2010.01.018_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(07)61048-4","article-title":"Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial","volume":"370","author":"Lazzarin","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2010.01.018_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)61047-2","article-title":"Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial","volume":"370","author":"Madruga","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2010.01.018_bib10","first-page":"S34","article-title":"Impact of baseline NNRTI mutations on the virological response to TMC125 in the phase III clinical trials DUET-1 and DUET-2","volume":"12","author":"Vingerhoets","year":"2007","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.jcv.2010.01.018_bib11","first-page":"S3","article-title":"An update of the list of NNRTI mutations associated with decreased virologic response to etravirine (ETR): multivariate analyses on the pooled DUET-1 and DUET-2 clinical trial data","volume":"13","author":"Vingerhoets","year":"2008","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.jcv.2010.01.018_bib12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/157016208785861230","article-title":"Evaluating the role of etravirine in the second-line antiretroviral therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting","volume":"6","author":"Sungkanuparph","year":"2008","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jcv.2010.01.018_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/135965350801300412","article-title":"Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors","volume":"13","author":"Lapadula","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jcv.2010.01.018_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jac\/dkn297","article-title":"Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz","volume":"62","author":"Llibre","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcv.2010.01.018_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/QAD.0b013e3282f3cc35","article-title":"Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA","volume":"22","author":"Bannistera","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2010.01.018_bib16","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/QAD.0b013e32832d8771","article-title":"Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples","volume":"23","author":"Kagan","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2010.01.018_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jac\/dkm372","article-title":"Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors","volume":"60","author":"Poveda","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcv.2010.01.018_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clinthera.2009.04.020","article-title":"A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV","volume":"31","author":"Schiller","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcv.2010.01.018_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jmv.21461","article-title":"Prediction of the virological response to etravirine in clinical practice: comparison of three genotype algorithms","volume":"81","author":"Cotte","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2010.01.018_bib20","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2006 revision). Available at http:\/\/www.who.int\/hiv\/pub\/guidelines\/artadultguidelines.pdf [accessed 3.9.2009]."},{"key":"10.1016\/j.jcv.2010.01.018_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1468-1293.2008.00644.x","article-title":"Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naive, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227","volume":"9","author":"Ruxrungtham","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.jcv.2010.01.018_bib22","first-page":"814","article-title":"Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand","volume":"38","author":"Wirachsilp","year":"2007","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.jcv.2010.01.018_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/aid.2008.0166","article-title":"Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain","volume":"25","author":"De Mendoza","year":"2009","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653210000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653210000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T13:27:24Z","timestamp":1711286844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653210000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1386653210000508"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2010.01.018","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}